Mitesco Secures $25,000 10% OID Convertible Bridge Note From ZSP Capital

Mitesco (MITI) secured a $25,000 convertible note from ZSP Capital, bearing 10% interest, maturing in 12 months with a $27,500 repayment. The note is convertible into Mitesco common stock at $0.15 per share. The financing aims to bolster liquidity and support ongoing initiatives, according to the company.

Original reporting
Published Oct 13, 2026, 10:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 10:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mitesco Secures $25,000 10% OID Convertible Bridge Note From ZSP Capital — source image
Decision brief

The 30-second read

$MITINeutralLow
01

Why it matters

The financing is a corporate action aimed at short‑term liquidity; given its modest size, market impact is expected to be negligible.

02

Market read

Primary disclosure of a small bridge note; limited trading relevance.

03

What to watch

Potential covenant terms or covenants tied to the note that could affect future financing flexibility.

Relevance 4/10Novelty 3/10Timing: post‑market today

Background

Mitesco Inc. (MITI) disclosed a bridge financing transaction via an 8‑K filing on Oct 13, 2026.

Company-level read

Ticker impact

$MITINeutralHigh confidence
Context

Mitesco filed an 8‑K announcing a $25,000 convertible bridge note with 10% OID, convertible at $0.15 per share, maturing in 12 months.

Expected impact

likely minimal pressure as investors may view the dilution risk as negligible given the small size.

Evidence & confidence

The amount is trivial for a public company and the conversion price is far below current market levels, so market reaction should be muted.

Market effects

No broader sector impact; the financing is company‑specific.

Limited to Mitesco shareholders; no regional effect.

None

Counterpoint

If the conversion price triggers future dilution, some investors may short the stock anticipating share count expansion.

Key entities

  • Mitesco Inc.

    Issuer of the bridge note.

  • ZSP Capital

    Counterparty providing the convertible bridge note.

Related articles

$SXTPHighAI 9/10

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc.…

60 DEGREES PHARMACEUTICALS, INC. (SXTP) filed an SEC Form 8-K — Other Events. Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On November 19, 2026, 60 Degrees Pharmaceuticals, Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Na

$PHOSMed

First Phosphate secures UK interest in $220M financing – ICYMI

First Phosphate Corp. (PHOS) secured a letter of interest from UK Export Finance for $220M in financing, adding to existing sovereign support. The company aims to develop a Quebec phosphate mine, crucial for LFP battery supply chains. Management expects feasibility studies by Q1 2027 and a final investment decision by Q2 2028, with nearly $600M in sovereign financing anticipated.